Zalutumumab
Zalutumumab ( proposed trade name HuMax-EGFR ) is a fully human IgG1 monoclonal antibody ( mAb ) directed towards the epidermal growth factor receptor ( EGFR ) . 
<triplet> Zalutumumab <subj> monoclonal antibody <obj> instance of